Released by The Lancet Commission on Reframing NCDs and Injuries for the Poorest Billion (The Lancet NCDI Poverty Commission) in September 2020, this landmark report highlights key findings and recommendations demonstrating the magnitude and pattern of the NCDI burden in several low and low-middle income countries (LLMICs) in Sub-Saharan Africa, the Caribbean, and South Asia as well as emphasizing the disparities existing in care and resources available for NCDs and injuries.
The H3Africa report discusses problems and solutions for population-based research to better understand the genomic variations in disease for sub-Saharan African populations. Research priorities proposed for NCDs include sickle cell disease, CVD, diabetes, and cancer, originally for consideration by the National Institutes for Health (NIH) and Wellcome Trust.
In this article, the authors investigate the experiences of stigma in families with a young child affected by sickle cell disorder (SCD) in Kenya and consider ways to counteract stigma in health, patient advocacy, community education, and research programs throughout sub-Saharan Africa.
In this article, the authors review the burden of disease of sickle cell disease (SCD), discuss the need for further clinical data especially in resource poor communities, discuss common clinical presentations of SCD in low-income countries, and present potential interventions to address SCD in these settings.
Using Tanzania as a case study, this article discusses opportunities for national health policy and possible clinical interventions to reduce under-five mortality from sickle cell disease, one of the most common childhood NCDs in sub-Saharan Africa.
NCD Synergies
HEALTH EQUITY FOR THE POOREST BILLION